Postoperative Management of Crohn Disease

Gastroenterology Clinics of North America

Volumn 38, Issue 4, 2009, Pages 753-762

  Cho, Su Min ^a   Cho, Sung W ^a   Regueiro, Miguel ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

5 ASA; Crohn disease; Immunomodulators; Infliximab; Postoperative; Prevention

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NITROIMIDAZOLE; ORNIDAZOLE; PLACEBO; SALAZOSULFAPYRIDINE;

ANASTOMOSIS; BIOLOGICAL THERAPY; CLINICAL TRIAL; COLONOSCOPY; CROHN DISEASE; DISEASE SURVEILLANCE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOSCOPY; HUMAN; INTESTINE RESECTION; MULTIPLE CYCLE TREATMENT; PANCREATITIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK MANAGEMENT; UNSPECIFIED SIDE EFFECT;

COLONOSCOPY; CROHN DISEASE; HUMANS; POSTOPERATIVE CARE; RECURRENCE; RISK FACTORS;

EID: 70449457420     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2009.07.008     Document Type: Review

References (36)

1. Bennell O., Lapidus A., and Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 231 (2000) 38-45
2. Fazio V.W., Marchetti F., Church M., et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial. Ann Surg 224 (1996) 563-571
3. Sachar D.B. The Problem of post operative recurrence of Crohn's disease. Med Clin North Am 74 (1990) 183-188
4. Renna S., Camma C., Modesto I., et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease. Gastroenterology 135 (2008) 1500-1509
5. Olaison G., Smedh K., and Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut 33 (1992) 331-335
6. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99 (1990) 956-983
7. Cameron J.L., Hamilton S.R., Coleman J., et al. Patterns of ileal recurrence in Crohn's disease: A prospective randomized study. Ann Surg (1992) 546-552
8. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 11 (2005) 3971-3979
9. Cosnes J., Carbonnel F., Beaugerie L., et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110 (1996) 424-431
10. Avidan B., Sakhnini E., Lahat A., et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 72 (2005) 563-571
11. Greenstein A.J., Lachman P., Sachar D.B., et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 29 (1988) 588-592
12. Lautenbach E., Berlin J.A., and Lichtenstein G.R. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 115 (1998) 259-267
13. Post S., Herfarth C., Bohm E., et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 223 3 (1996) 253-260
14. Munoz-Juarez M., Yamamoto T., Wolff B.G., et al. Wide-lumen stapled anastomosis vs. conventional end-to end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 44 (2001) 20-25
15. Caprilli R., Corrao G., Taddei G., et al. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum 39 (1996) 335-341
16. Scarpa M., Ruffolo C., Bertin E., et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis 22 (2007) 1061-1069
17. Viscido A., Corrao G., Taddei G., et al. Crohn's disease activity index is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Ital J Gastroenterol Hepatol 31 (1999) 274-279
18. Wenckert A., Kristensen M., Eklund A.E., et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Scand J Gastroenterol 13 (1978) 161-167
19. Summers R.W., Switz D.M., Sessions Jr. J.T., et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 77 4 Pt 2 (1979) 847-869
20. Lochs H., Mayer M., Fleig W.E., et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 118 (2000) 264-273
21. Caprilli R., Andreoli A., Capurso L., et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 8 (1994) 35-43
22. Florent C., Cortot A., Quandale P., et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 8 (1996) 229-233
23. Ewe K., Herfarth C., Malchow H., et al. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion 42 (1989) 224-232
24. Brignola C., Cottone M., Pera A., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 108 (1995) 345-349
25. Mcleod R.S., Wolff B.G., Steinhart A.H., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 109 (1995) 404-413
26. Caprilli R., Cottone M., Tonelli F., et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 17 (2003) 517-523
27. Camma C., Giunta M., Rosselli M., et al. Mesalamine in the maintenance treatment of Crohn's disease: a metaanalysis adjusted for confounding variables. Gastroenterology 113 (1997) 1465-1473
28. Rutgeerts P., Hiele M., Geboes K., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108 (1995) 1617-1621
29. Rutgeerts P., Van Assache G., Vermeire S., et al. Ornidazole for prophylaxis of post-operative Crohn's disease recurrence: a randomized, double blind, placebo-controlled trial. Gastroenterology 128 (2005) 856-861
30. Hellers G., Cortot A., Jewell D., et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 116 (1999) 294-300
31. Ewe K., Bottger T., Buhr H.J., et al. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 11 (1999) 277-282
32. Ardizzone S., Maconi G., Sampietro G.M., et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 127 (2004) 730-740
33. Hanauer S.B., Korelitz B.I., Rutgeerts P., et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127 (2004) 723-729
34. D'Haens G., Vermeire S., Van Assche G., et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 135 4 (2008 Oct) 1123-1129
35. Regueiro M., Schraut W., Baidoo L., et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 136 (2009) 441-450
36. Regueiro M. Management and prevention of postoperative Crohn's disease. Inflamm Bowel Dis (2009) [Epub ahead of print]